🚀 VC round data is live in beta, check it out!

Laboratorio Farmaceutico Valuation Multiples

Discover revenue and EBITDA valuation multiples for Laboratorio Farmaceutico and similar public comparables like Misitano & Stracuzzi, Fountain, New Nordic Healthbrands, Kalve Coffee and more.

Laboratorio Farmaceutico Overview

About Laboratorio Farmaceutico

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.


Founded

2013

HQ

Italy

Employees

33

Website

erfo.it

Financials (FY)

Revenue: $7M
EBITDA: $1M

EV

$12M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Laboratorio Farmaceutico Financials

Laboratorio Farmaceutico reported last fiscal year revenue of $7M and EBITDA of $1M.

In the same fiscal year, Laboratorio Farmaceutico generated $5M in gross profit, $1M in EBITDA, and $430K in net income.


Laboratorio Farmaceutico P&L

In the most recent fiscal year, Laboratorio Farmaceutico reported revenue of $7M and EBITDA of $1M.

Laboratorio Farmaceutico is profitable as of last fiscal year, with gross margin of 72%, EBITDA margin of 21%, and net margin of 6%.

See analyst estimates for Laboratorio Farmaceutico
Last FY20232024202620272028
Revenue$7M$7M$7M
Gross Profit$5M$5M$5M
Gross Margin72%72%72%
EBITDA$1M$2M$1M
EBITDA Margin21%26%21%
EBIT Margin10%15%10%
Net Profit$430K$649K$430K
Net Margin6%9%6%
Net Debt$7K

Financial data powered by Morningstar, Inc.

Laboratorio Farmaceutico Stock Performance

Laboratorio Farmaceutico has current market cap of $11M, and enterprise value of $12M.

Market Cap Evolution


Laboratorio Farmaceutico's stock price is $1.35.

Laboratorio Farmaceutico share price increased by 0.4% in the last 30 days, and decreased by 2.2% in the last year.

Laboratorio Farmaceutico has an EPS (earnings per share) of $0.05.

See more trading valuation data for Laboratorio Farmaceutico
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$12M$11M-0.0%0.4%-8.3%-2.2%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Laboratorio Farmaceutico Valuation Multiples

Laboratorio Farmaceutico trades at 1.7x EV/Revenue multiple, and 8.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Laboratorio Farmaceutico

Laboratorio Farmaceutico Financial Valuation Multiples

As of May 3, 2026, Laboratorio Farmaceutico has market cap of $11M and EV of $12M.

Laboratorio Farmaceutico has a P/E ratio of 26.7x.

Last FY20232024202620272028
EV/Revenue1.7x1.7x1.7x
EV/EBITDA8.2x6.5x8.2x
EV/EBIT16.9x11.0x16.9x
EV/Gross Profit2.3x2.4x2.3x
P/E26.7x17.7x26.7x
EV/FCF14.0x(68.3x)14.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Laboratorio Farmaceutico Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Laboratorio Farmaceutico Margins & Growth Rates

In the most recent fiscal year, Laboratorio Farmaceutico reported gross margin of 72%, EBITDA margin of 21%, and net margin of 6%.

See estimated margins and future growth rates for Laboratorio Farmaceutico

Laboratorio Farmaceutico Margins

Last FY2024202720282029
Gross Margin72%72%
EBITDA Margin21%21%
EBIT Margin10%10%
Net Margin6%6%
FCF Margin12%12%

Laboratorio Farmaceutico Growth Rates

23/2426/2727/2828/29
Revenue Growth2%
Gross Profit Growth2%
EBITDA Growth(21%)
EBIT Growth(35%)
Net Profit Growth(34%)
FCF Growth(588%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Laboratorio Farmaceutico Operational KPIs

Laboratorio Farmaceutico's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Laboratorio Farmaceutico
Last FY20232024202620272028
Revenue per Employee$0.2M
Opex per Employee$0.1M
Opex to Revenue62%56%62%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Laboratorio Farmaceutico Competitors

Laboratorio Farmaceutico competitors include Misitano & Stracuzzi, Fountain, New Nordic Healthbrands, Kalve Coffee, Ecomiam, Willamette Valley, Empresa Agricola Sintuco, Biogena, Paulic Meunerie and Industrias Productos Alimenticios.

Most Laboratorio Farmaceutico public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Misitano & Stracuzzi0.7x3.0x
Fountain0.5x4.2x
New Nordic Healthbrands0.2x6.8x
Kalve Coffee1.4x47.9x
Ecomiam0.3x0.3x(5.0x)(6.2x)
Willamette Valley2.3x27.2x
Empresa Agricola Sintuco
Biogena34.7x41.0x

This data is available for Pro users. Sign up to see all Laboratorio Farmaceutico competitors and their valuation data.

Start Free Trial

Laboratorio Farmaceutico M&A Activity

Laboratorio Farmaceutico has acquired 1 company to date.

Last acquisition by Laboratorio Farmaceutico was on December 30th 2024. Laboratorio Farmaceutico acquired Fit And Go for $5M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Laboratorio Farmaceutico

Fit And Go
Description
Milan-based Fit And Go operates a chain of 15 EMS gyms across Italy offering 20-minute electro-muscle stimulation sessions combined with bodyweight circuits and personal training. Each studio features Miha Bodytec suits delivering up to 30,000 muscle contractions per workout, certified by TÜV for safety. Founded in 2017, the franchise model expands to Rome and Turin locations with memberships starting at group classes tracked via proprietary app.
HQ CountryItaly
HQ City
Rome
Deal Date30 Dec 2024
Valuation$5M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Laboratorio Farmaceutico acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Laboratorio Farmaceutico

When was Laboratorio Farmaceutico founded?Laboratorio Farmaceutico was founded in 2013.
Where is Laboratorio Farmaceutico headquartered?Laboratorio Farmaceutico is headquartered in Italy.
How many employees does Laboratorio Farmaceutico have?As of today, Laboratorio Farmaceutico has over 33 employees.
Is Laboratorio Farmaceutico publicly listed?Yes, Laboratorio Farmaceutico is a public company listed on Borsa Italiana.
What is the stock symbol of Laboratorio Farmaceutico?Laboratorio Farmaceutico trades under ERFO ticker.
When did Laboratorio Farmaceutico go public?Laboratorio Farmaceutico went public in 2022.
Who are competitors of Laboratorio Farmaceutico?Laboratorio Farmaceutico main competitors include Misitano & Stracuzzi, Fountain, New Nordic Healthbrands, Kalve Coffee, Ecomiam, Willamette Valley, Empresa Agricola Sintuco, Biogena, Paulic Meunerie, Industrias Productos Alimenticios.
What is the current market cap of Laboratorio Farmaceutico?Laboratorio Farmaceutico's current market cap is $11M.
What is the current revenue of Laboratorio Farmaceutico?Laboratorio Farmaceutico's last fiscal year revenue is $7M.
What is the current EV/Revenue multiple of Laboratorio Farmaceutico?Current revenue multiple of Laboratorio Farmaceutico is 1.7x.
Is Laboratorio Farmaceutico profitable?No, Laboratorio Farmaceutico is not profitable.
How many companies Laboratorio Farmaceutico has acquired to date?As of May 2026, Laboratorio Farmaceutico has acquired 1 company.
What was the largest acquisition by Laboratorio Farmaceutico?$5M acquisition of Fit And Go on 30th December 2024 was the largest M&A Laboratorio Farmaceutico has done to date.
What companies Laboratorio Farmaceutico acquired?Laboratorio Farmaceutico acquired Fit And Go.
In how many companies Laboratorio Farmaceutico has invested to date?Laboratorio Farmaceutico hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Laboratorio Farmaceutico

Lists including Laboratorio Farmaceutico

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial